Pharmena S.A. (PHR) — Net Asset Quality Index
Pharmena S.A. (PHR) has a Net Asset Quality Index of 92.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of zł11.39 Million minus total liabilities of zł850.00K yields net assets of zł10.54 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Pharmena S.A. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pharmena S.A. Net Asset Quality Index Over Time (2008–2024)
This chart shows how Pharmena S.A.'s Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the index stands at 92.5%, representing net assets of zł10.54 Million against total assets of zł11.39 Million PLN. Explore PHR cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Pharmena S.A. (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for Pharmena S.A. from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see PHR market cap.
| Year | Quality Index | Net Assets (PLN) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.8% | zł12.42 Million | zł13.53 Million | zł1.11 Million | ▼ -0.3 pp |
| 2023 | 92.1% | zł22.23 Million | zł24.13 Million | zł1.91 Million | ▲ +146.1 pp |
| 2022 | -54.0% | zł-6.79 Million | zł12.58 Million | zł19.37 Million | ▼ -8.1 pp |
| 2021 | -45.9% | zł-5.12 Million | zł11.15 Million | zł16.27 Million | ▼ -42.7 pp |
| 2020 | -3.2% | zł-348.00K | zł10.95 Million | zł11.30 Million | ▼ -45.7 pp |
| 2019 | 42.6% | zł5.00 Million | zł11.74 Million | zł6.74 Million | ▲ +14.1 pp |
| 2018 | 28.5% | zł1.94 Million | zł6.80 Million | zł4.87 Million | ▼ -3.6 pp |
| 2017 | 32.1% | zł3.56 Million | zł11.10 Million | zł7.54 Million | ▼ -9.5 pp |
| 2016 | 41.6% | zł5.94 Million | zł14.28 Million | zł8.34 Million | ▼ -15.6 pp |
| 2015 | 57.2% | zł8.67 Million | zł15.16 Million | zł6.49 Million | ▼ -20.4 pp |
| 2014 | 77.6% | zł13.08 Million | zł16.86 Million | zł3.78 Million | ▼ -10.2 pp |
| 2013 | 87.8% | zł18.05 Million | zł20.56 Million | zł2.51 Million | ▲ +10.3 pp |
| 2012 | 77.5% | zł8.98 Million | zł11.59 Million | zł2.61 Million | ▼ -13.7 pp |
| 2011 | 91.1% | zł16.45 Million | zł18.05 Million | zł1.60 Million | ▼ -3.4 pp |
| 2010 | 94.6% | zł15.91 Million | zł16.82 Million | zł912.97K | ▲ +0.0 pp |
| 2009 | 94.5% | zł16.16 Million | zł17.09 Million | zł934.89K | ▼ -1.0 pp |
| 2008 | 95.5% | zł15.78 Million | zł16.52 Million | zł735.26K | — |